Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 26: ORBITA-CTO - PCI vs Placebo in Stable Angina
Author(s): Sarosh Khan , John Davies Added: 2 months ago
American College of Cardiology Congress 2026 - Dr Sarosh Khan and Dr John Davies (Essex Cardiothoracic Centre, Basildon, UK) join us to discuss results from the ORBITA-CTO trial (NCT05142215; Mid and South Essex NHS Foundation Trust), a randomised, placebo-controlled study evaluating CTO PCI versus placebo for the relief of stable angina.This double-blind, randomised, placebo-controlled pilot… View more

Intervention

Prevention & Chronic Conditions
The Role of Coronary Sinus Reducer Implantation for Refractory Angina
Author(s): Kevin Cheng , Jonathan M Hill , Ranil de Silva Added: 1 year ago

Intervention

Prevention & Chronic Conditions
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 9 months ago

Intervention

Prevention & Chronic Conditions
llateral Flow Linked to Reduced Angina Pain in CAD
Added: 6 months ago Source:  Radcliffe Cardiology
A study has found that while the severity of ischaemia correlates poorly with daily angina symptoms in patients with stable coronary artery disease (CAD), the development of coronary collateral circulation is associated with both the ischaemic burden and reduced intensity of ischaemic chest pain.¹ This may help explain the often-observed disconnect between stenosis severity and patient-reported… View more

Demographic

Intervention
Added: 4 months ago Source:  Radcliffe Cardiology
The long-term benefits of revascularization over medical therapy for patients with stable coronary artery disease (CAD) remain a subject of clinical debate. New long-term follow-up data from the Fractional Flow Reserve versus Angiography for Multivessel Evaluation 2 (FAME 2) trial provide further insight, demonstrating a sustained benefit for percutaneous coronary intervention (PCI) guided by… View more

Guidelines & Statements

Intervention
Invasive Strategy Linked to More Favourable Angina Trajectories in Chronic Coronary Disease
Added: 9 months ago Source:  Transcatheter Academy
While clinical trials typically report average health outcomes at specific time points, a new secondary analysis of the ISCHEMIA trial has delved into the individual patient journeys of angina symptoms over time. The study identified six distinct patterns of angina trajectories, revealing that an initial invasive strategy is associated with more favourable symptom pathways compared to a… View more

Intervention

Prevention & Chronic Conditions
ACC 25: The EKSTROM Trial
Author(s): Matthew J Budoff Added: 1 year ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical… View more

Intervention
Research Area(s) / Expertise:
Prof Stables is consultant cardiologist at LHCH — a specialist cardiothoracic unit and, in terms of procedure volume, one of the largest cardiac units in Europe. Prof Stables was the Chair of the Academic and Research Committee at the British Cardiovascular Society. View more
Juan Carlos Kaski
Research Area(s) / Expertise: Job title: Professor of Cardiovascular Science
Professor Juan Carlos Kaski is an internationally renowned cardiologist and academic based in London, United Kingdom. He currently holds the position of Professor of Cardiovascular Science (Emeritus) at the Molecular and Clinical Sciences Research Institute, St George’s, University of London, and serves as Honorary Consultant Cardiologist at both St George’s Hospital and The Royal Brompton… View more
Dr Eva Prescott
Research Area(s) / Expertise:

Cardiac Rehabilitation Programmes

 Job title: Professor at Bispebjerg Hospital, Department of Cardiology, Copenhagen, Denmark
Academic History Dr Eva Prescott studied at Greve Gymnasium in Greve, Denmark from 1977 to 1980. Later on, she became an MD at the University of Copenhagen, where she studied from 1981 to 1990. Career Overview Dr Prescott leads the Centre for Cardiovascular Research at Bispebjerg Frederiksberg University Hospital, Copenhagen. Her main research areas include angina pectoris, cardiac… View more